European Equities Close Higher in Tuesday Trading; German Economy Stagnates in Q3

12:16 PM EST, 11/25/2025 (MT Newswires) -- The European stock markets closed higher in Tuesday trading as The Stoxx Europe rose 0.9%, Germany's DAX gained about 1%, the FTSE 100 was up 0.8%, France's CAC advanced 0.8%, and the Swiss Market Index increased 0.9%.

The German economy was stagnant in Q3 as gross domestic product, adjusted for price, seasonal and calendar effects, recorded no growth from Q2, according to the Federal Statistical Office.

"Economic activity was hampered in the third quarter by weak exports, while investments increased slightly," Federal Statistical Office President Ruth Brand said.

Compared with a year earlier, GDP grew 0.3% in real terms, as well as adjusting for price and calendar effects, it was also 0.3% higher.

In France, the household confidence index declined to 89 in November from 90 the previous month, according to the Institute for Statistics and Economic Studies, or INSEE. The score remains well off its long-term average of 100 between January 1987 and December 2024.

"Households' opinion on the opportunity to save has reached a new historic maximum this month," INSEE said.

In corporate news, Novo Nordisk said Tuesday a phase 2 trial of its experimental drug amycretin in people with type 2 diabetes showed reductions in weight and HbA1c or average blood sugar. Based on the findings, Novo Nordisk plans to start a phase 3 development program with amycretin for adults with type 2 diabetes in 2026, it said.

Shares of the Danish pharmaceutical company advanced 4.5% in Copenhagen.

Sanofi said its premises were visited on Tuesday by authorities as part of an investigation into a financing arrangement offered by Societe Generale more than a decade ago.

The company said the mechanism is under review by the French National Financial Prosecutor's Office and that it believes it complied with all applicable laws and regulations. Sanofi added that it will cooperate with authorities.

Shares of the French pharmaceutical company rose 0.5% in Paris.

TotalEnergies said Tuesday it has decided to demobilize its liquefied natural gas floating storage and regasification unit at the Le Havre port in France.

The company said the floating LNG terminal is no longer needed, as shown by its lack of use and as stated in an Oct. 16 ruling by the Rouen Administrative Court.

Shares of the French oil and gas company were up 0.5% in Paris.

Swiss pharmaceutical company Novartis reported Monday that the US Food and Drug Administration has approved itvisma to treat spinal muscular atrophy, or SMA.

The gene replacement therapy is for children aged two years and older, teens, and adults, the company said, adding that the treatment addresses the genetic root cause of SMA with a one-time fixed dose that does not need to be adjusted for age or body weight. Itvisma will be available in the US in December.

Shares of Novartis gained 1.5% in Zurich.

MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.